Alexza Pharmaceuticals — Investor Relations - RSS Content

Links shared publicly online about this topic.

  • 95
    total visits

Alexza Pharmaceuticals — Investor Relations - RSS Content

phx.corporate-ir.net —

Alexza Pharmaceuticals Welcome

View full resource at phx.corporate-ir.net

Tags: Bipolar Disorder, Schizophrenia, Psychotic Disorder, Disease and Condition, Pharma, FDA

  • Share

Most Recently Shared on August 5, 2011 at 1:15 pm By:

eyeonfda eyeonfda

Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA 4 #Schizophrenia or #Bipolar Disorder - http://ow.ly/5VZLR #FDA

9 months ago...

Reply

Retweet

Favorite

Advertisement